101
|
Sun F, Tian M, Sun X, Xu T, Liu X, Zhu S, Zhang X, Qu L. Stretchable Conductive Fibers of Ultrahigh Tensile Strain and Stable Conductance Enabled by a Worm-Shaped Graphene Microlayer. NANO LETTERS 2019; 19:6592-6599. [PMID: 31434486 DOI: 10.1021/acs.nanolett.9b02862] [Citation(s) in RCA: 48] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Stretchable electrical conductors have demonstrated promising potentials in a wide range of wearable electronic devices, but the conductivity of most reported stretchable conductive fibers will be changed if be stretched or strained. Stable conductance is essential for wearable and stretchable devices, to ensure the performance is stable. Inspired by the peristaltic behavior of arthropods, we designed a graphene coating similar to the caterpillar structure on the polyurethane (PU) fiber surface, enabled by coating the worm-shaped graphene microlayer onto polyurethane filaments. Such worm-shaped filaments can be stretched up to 1010% with a wide reversible electroresponse range (0 < ε < 815%), long-term durability (>4000 stretching/releasing cycles), good initial conductivity (σ0 = 124 S m-1), and high quality factor (Q = 11.26). Remarkably, the worm-shaped filaments show distinctive strain-insensitive behavior (ΔR/R0 < 0.1) up to 220% strain. Furthermore, the filaments as electrical circuits of light emitting diodes (LEDs) to track signals from robust human joint movements are also demonstrated for practical application. Such worm-shaped filaments with distinctive strain-insensitive behavior provide a direct pathway for stretchy electronics.
Collapse
|
102
|
Sun F, Zhou K, Chen XD, Xu XL, Zha DJ. [Screening and antibiotic resistance analysis of nasal colonized bacteria in patients with chronic rhinosinusitis]. LIN CHUANG ER BI YAN HOU TOU JING WAI KE ZA ZHI = JOURNAL OF CLINICAL OTORHINOLARYNGOLOGY, HEAD, AND NECK SURGERY 2019; 33:736-741. [PMID: 31446729 DOI: 10.13201/j.issn.1001-1781.2019.08.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 02/21/2019] [Indexed: 11/12/2022]
Abstract
Objective:Since bacterial infection is one of the common pathogenic factors lead to chronic rhinosinusitis (CRS), our study is designed to investigate the prevalence and antibiotic resistance of nasal colonized bacteria in patients with CRS, and to analyze the correlation between nasal colonized bacteria and pathogenesis of CRS. Method:Nasal vestibule samples collected from 200 patients with CRS were automatically inoculated on to various bacterial culture medium, cultured by WaspLab microbiology automated system, potential pathogenic bacterial colonies grew on agar plates were then examined, identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry, and analyzed their antibiotic-resistant phenotype by antibiotic susceptibility testing. Result:Two hundred and seventy-five bacterial strains of nasal colonization were isolated, including coagulase-negative Staphylococci, Staphylococcus aureus, Streptococcus pneumonia, Moraxella catarrhalis, Haemophilus influenza, Pseudomonas aeruginosa, and Enterobacteriaceae such as Escherichia coli and Klebsiella pneumoniae. All strains displayed various degrees of antimicrobial resistance among children and adult patients, or among patients with and without endoscopic sinus surgery. Conclusion:The constitution of nasal colonized commensal bacteria in patients with CRS was partially similar to that of pathogenic bacteria causing CRS. They may form a reservoir of antimicrobial resistant pathogens, which would transform into pathogenic bacteria causing CRS under certain conditions. Screening of nasal colonized bacteria may represent an alternative approach for diagnosis and treatment of CRS.
Collapse
|
103
|
Wang Y, Wang Z, Ding Y, Sun F, Ding X. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer. Asian Pac J Cancer Prev 2019; 20:2405-2407. [PMID: 31450913 PMCID: PMC6852827 DOI: 10.31557/apjcp.2019.20.8.2405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2019] [Indexed: 11/25/2022] Open
Abstract
Background: To investigate the clinical value of HE4 detection in the diagnosis of lung cancer and the clinical significance of combined detection with CEA, NSE and CYFRA21-1. Methods: 90 cases of lung cancer, 30 cases of pulmonary tuberculosis, 30 cases of pneumonia and 30 cases of health physical examination were selected. The levels of serum HE4, CYFRA21-1, CEA and NSE were detected by electrochemiluminescence method. Statistical analysis was performed to observe the sensitivity and specificity. Results: The levels of serum HE4, CEA, NSE and CYFRA21-1 in lung cancer group were significantly higher than those in tuberculosis group and health physical examination group. There was no significant difference in the levels of HE4, CEA and NSE between the lung cancer group and the pneumonia group, the difference of CYFRA21-1 level was statistically significant (p<0.05).With health physical examination group as normal controls, the sensitivity and specificity of combined detection of HE4, CEA, NSE and CYFRA21-1 in the diagnosis of lung cancer were 82.2% and 90.0%,and the area under the curve (AUC) was 0.907, followed by HE4 (0.867), CYFRA21-1 (0.787), CEA (0.752) and NSE (0.747). Conclusion: HE4 can be used as a serological marker for the diagnosis of lung cancer. The combined detection of HE4, CEA, NSE and CYFRA21-1 can improve the diagnosis of lung cancer. Serum HE4 levels are highly specific in distinguishing between lung cancer patients and normal population, and are equivalent to CYFRA21-1; but they are less specific than CYFRA21-1 in distinguishing lung cancer patients from pneumonia patients.
Collapse
|
104
|
Zhang G, Wang WW, Yang ZR, Zhan SY, Sun F. [Introduction to PRISMA-CI extension statement and checklist systematic reviews on complex interventions]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2019; 40:832-838. [PMID: 31357807 DOI: 10.3760/cma.j.issn.0254-6450.2019.07.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Comprehensive interventions have been widely used in health system, public health, education and communities and have become increasingly focus of systematic reviews. There have been many reporting guidelines about systematic reviews, but they do not take the features of comprehensive interventions in medical area into consideration. As a result, PRISMA-CI has been developed as an extension of PRISMA, which adds or modifies the essential items of PRISMA. This paper introduces the items of PRISMA-CI and explains the items with an example to help authors, publishers, and readers understand PRISMA-CI and use it in systematic reviews on comprehensive interventions. As it become more and more popular with comprehensive interventions, PRISMA-CI will provide important structure and guidance for its systematic review and Meta-analysis.
Collapse
|
105
|
Zhu Y, Li Y, Zhang S, Zhang X, Yao J, Luo Q, Sun F, Wang X. Genome-wide identification and expression analysis reveal the potential function of ethylene responsive factor gene family in response to Botrytis cinerea infection and ovule development in grapes (Vitis vinifera L.). PLANT BIOLOGY (STUTTGART, GERMANY) 2019; 21:571-584. [PMID: 30468551 DOI: 10.1111/plb.12943] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Accepted: 11/16/2018] [Indexed: 05/02/2023]
Abstract
The prevention of Botrytis cinerea infection and the study of grape seedlessness are very important for grape industries. Finding correlated regulatory genes is an important approach towards understanding their molecular mechanisms. Ethylene responsive factor (ERF) gene family play critical roles in defence networks and the growth of plants. To date, no large-scale study of the ERF proteins associated with pathogen defence and ovule development has been performed in grape (Vitis vinifera L.). In the present study, we identified 113 ERF genes (VvERF) and named them based on their chromosome locations. The ERF genes could be divided into 11 groups based on a multiple sequence alignment and a phylogenetic comparison with homologues from Arabidopsis thaliana. Synteny analysis and Ka/Ks ratio calculation suggested that segmental and tandem duplications contributed to the expansion of the ERF gene family. The evolutionary relationships between the VvERF genes were investigated by exon-intron structure characterisation, and an analysis of the cis-acting regulatory elements in their promoters suggested potential regulation after stress or hormone treatments. Expression profiling after infection with the fungus, B. cinerea, indicated that ERF genes function in responses to pathogen attack. In addition, the expression levels of most ERF genes were much higher during ovule development in seedless grapes, suggesting a role in ovule abortion related to seedlessness. Taken together, these results indicate that VvERF proteins are involved in responses to Botrytis cinerea infection and in grape ovule development. This information may help guide strategies to improve grape production.
Collapse
|
106
|
Gao L, Yu SQ, Yang JC, Ma JL, Zhan SY, Sun F. [Quality assessment of global guidelines on colorectal cancer screening]. JOURNAL OF PEKING UNIVERSITY. HEALTH SCIENCES 2019; 51:548-555. [PMID: 31209430 DOI: 10.19723/j.issn.1671-167x.2019.03.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
OBJECTIVE To systematically review and assess the quality of guidelines on colorectal cancer screening worldwide to provide guidance for the development of high-quality colorectal cancer screening guidelines in mainland China. METHODS CNKI, WanFang Data, VIP, SinoMed, PubMed, Embase, and Web of Science were systematically searched to identify guidelines on colorectal cancer screening from inception to Jun. 20th, 2018, and so were some websites and major search engines about the development of the guidelines from the existing literature (search date: Aug. 3rd, 2018). Two experienced reviewers independently examined these abstracts and then extracted information, and the Appraisal of Guidelines for Research and Evaluation II (AGREE II) were used to evaluate the methodological quality of these guidelines by four well trained reviewers. RESULTS In this study, 46 guidelines published from 1994 to 2018 were finally included in our analysis from 10 countries and 5 regions, among which 5 were from mainland China. The quality of these guidelines was relatively high in domain 1 (scope and purpose) and domain 4 (clarity of presentation), and medium in domain 2 (stakeholder involvement). While in the other three domains (domain 3: rigour of development; domain 5: applicability; domain 6: editorial independence), the results were quite different among these guidelines. The quality of evidence-based guidelines (defined by the criteria based on World Health Organization guideline development handbook) was generally higher than that of the common guidelines. Existing guidelines from mainland China were not evidence-based guidelines, which were of low quality. CONCLUSION The colorectal cancer screening guidelines all over the world are generally large in number, low in quality, different in statements, and so are the guidelines in China. There are no evidence-based guidelines in mainland China, which cannot provide effective guidance for colorectal cancer screening, so we need to pay more attention to the establishment of guidelines with high quality and high credibility for colorectal cancer screening as well as for cancer screening based on the national condition, in order to provide reasonable guidance for practice in public health and improve the health conditions in our society.
Collapse
|
107
|
Song L, He J, Gao Y, Fang Y, Zhang L, Wang J, Sun F, Zhang F, Zeng Y, Zeng F, Zhang J. Improved biosafety of a lentiviral vector by reducing cellular gene activation. J Gene Med 2019; 21:e3087. [PMID: 30901108 DOI: 10.1002/jgm.3087] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2018] [Revised: 03/07/2019] [Accepted: 03/08/2019] [Indexed: 01/16/2023] Open
Abstract
BACKGROUND Lentiviral vectors (LVs) have enhancer activity and/or transcriptional read-through (EATRT) properties that can lead to the activation of adjacent genes. Consequently, patients may be at increased risk for adverse effects if such vectors are used clinically. METHODS In the present study, we assessed the abilities of different "pro-LV"-like constructs with respect to decreasing its EATRT, including the "pro-LV" vector bearing a chimeric ΔLTR of the human foamy virus R-U5 region replaced by that of an LV (HF). RESULTS By analyzing the EATRT of "pro-LV" constructs transfected in 293T cells, we observed that the inclusion of the first 400 bp of the chicken β-globin locus HS4 insulator core sequence oriented in the reverse direction (C-) combined with two copies of the simian virus 40 upstream-sequence element (U) at the ΔU3 of ΔLTR region of "pro-LV" tended to shield the adjacent genomic sequences, such that the EATRT rate was lower than when either of the C- or U was included in the "pro-LV". Moreover, upon transduction, the pro-HF appears to reduce the EATRT rate in the chromosomes of 293T (by 80%) and human peripheral blood mononuclear cells (PBMCs) (by 75%) compared to when pro-LV C-U was included (with a 60% and 89% reduction in 293T and PBMCs, respectively). The HF construct had a significant reduction of viral biological titer compared tiowhen the pro-LV C-U was used in 293T cells. CONCLUSIONS The results of the present study provide an important basis for the clinical applicability of LVs in gene and cell therapy.
Collapse
|
108
|
Chen Z, Zhao Y, Tan Y, Xin Y, Deng J, Sun F, He G. Photochemical preparation of SnO2 nanoparticles for application in alcohol sensor. ACTA ACUST UNITED AC 2019. [DOI: 10.1088/1757-899x/490/2/022049] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
109
|
Sun F, Banfill K, Lilley J, Wheller B, Murray L, McWilliam A, Van Herk M, Abravan A, Faivre-Finn C, Franks K. Multi-centre analysis of cardiac events following radical radiotherapy for lung cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz064.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
110
|
Tang SW, Zhang Y, Tao BL, Yang ZR, Sun F, Zhan SY. [Risk of bias assessment: (7) Assessing Bias in Studies of Prognostic Factors]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2019; 39:1003-1008. [PMID: 30060320 DOI: 10.3760/cma.j.issn.0254-6450.2018.07.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
This paper introduces the tools related to Quality In Prognosis Studies (QUIPS) to assess the risk of bias in studies of prognostic factors and the relevant points of assessment and to illustrate the application of QUIPS in published prognostic research. The QUIPS tool identified 6 important areas to consider when evaluating validity and bias in studies of prognostic factors including participation, attrition, measurement on prognostic factors, outcomes, confounding factors, statistical analysis and reporting. It also provided a new method for evaluation on bias in the areas of prognostic research.
Collapse
|
111
|
Yang ZR, Sun F, Zhan SY. [Risk of bias assessment: (1) overview]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2019; 38:983-987. [PMID: 28738479 DOI: 10.3760/cma.j.issn.0254-6450.2017.07.027] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
This paper reviews the concept of risk of bias, followed by demonstrating why assessment of risk of bias in systematic reviews should be different from that of quality of evidence, methodological quality, reporting quality, precision, and external validity. We also discuss the recent development of tools for risk of bias assessment, the problems with the tools themselves, and the challenges in using these tools. This review may help systematic reviewers understand risk of bias assessment and the use of assessment tools.
Collapse
|
112
|
Daniell KM, Bardia A, Sun F, Brunelle CL, Gillespie TC, Sayegh HE, Naoum GE, Isakoff SJ, Juric D, Taghian AG. Abstract P3-14-02: Upper extremity edema in the at-risk arm among patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p3-14-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Targeted therapies, including mTOR and CDK 4/6 inhibitors, have changed the landscape of management of hormone receptor-positive (HR+) metastatic breast cancer (MBC). These therapies have shown significant improvement in progression-free survival and are generally well-tolerated. In pre-clinical models, modulation of the PI3K/mTOR pathway can impede lymphoangiogenesis resulting in capillary leakage. In this study, we examined the impact of PI3K, mTOR, and CDK 4/6 inhibitors in the development of upper extremity edema (UEE) in the at-risk arm for breast cancer-related lymphedema (BCRL) in patients with MBC.
Methods: We conducted a retrospective chart review of patients treated with PI3K/mTOR/CDK4/6 inhibitors for MBC. Clinicopathologic data including age, body-mass index (BMI), specific pathway targeted, treatment duration, and presence of edema were recorded. Characteristics of treatment including surgery type and laterality, nodal surgery, radiation regimen, and tumor subtype were also collected.
Results: Among patients with MBC treated with PI3K, mTOR, and/or CDK 4/6 inhibitors (N = 160), the incidence of edema that developed after initiation of the targeted therapy was 11.3% (18/160) for UEE and 31.9% (51/160) for edema in any anatomical location. 50.0% (11/22) of patients treated with a PI3K-a inhibitor, 32.6% (14/43) of patients treated with an mTOR inhibitor, and 33.3% (8/24) of patients treated with a CDK4/6 inhibitor alone developed peripheral edema following initiation of the respective targeted therapy. Further, swelling developed in the at-risk upper extremity after C1D1 in 13.6% (3/22) patients treated with a PI3K-α inhibitor exclusively, 7.0% (3/43) treated with an mTOR inhibitor exclusively, and in 12.5% (3/24) treated with a CDK4/6 inhibitor exclusively. Of the 42 patients treated with a CDK4/6 inhibitor in combination with either an mTOR inhibitor, aromatase inhibitor, or an ER-binding promoter, the incidence of UEE in the at-risk upper extremity after C1D1 was 18.8% (6/32), 0.0% (0/7), and 0.0% (0/3) respectively. In multivariate logistic regression analysis, both therapy with PI3K-a inhibitors (OR: 3.22; p = 0.049) and a relative decrease in serum albumin after 3 months of treatment (OR: 3.35, p = 0.024) increased the risk of developing peripheral edema; however, duration of therapy, and nodal surgery were not significant risk factors. Upon stratification of this cohort by number of BCRL-related risk factors, the incidence of BCRL was 18.3%, 39.5%, and 83.3% in women with one, two, or three BCRL-related risk factors, respectively.
Conclusions: PI3K, mTOR, and CDK 4/6 inhibitors may influence the development of UEE, which may cause or exacerbate progression of BCRL in at-risk arm among patients with MBC. Further research is needed to prospectively evaluate these novel findings as well as elucidate physiologic and clinical impacts of these therapies on peripheral edema and BRCL. Moreover, it is crucial to understand the role of close monitoring for the development or progression of peripheral edema or BCRL to ensure early detection and treatment, thus potentially minimizing the negative impacts on the quality of life of patients with MBC.
Citation Format: Daniell KM, Bardia A, Sun F, Brunelle CL, Gillespie TC, Sayegh HE, Naoum GE, Isakoff SJ, Juric D, Taghian AG. Upper extremity edema in the at-risk arm among patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-14-02.
Collapse
|
113
|
Sun F, Aguerre MJ, Wattiaux MA. Starch and dextrose at 2 levels of rumen-degradable protein in iso-nitrogenous diets: Effects on lactation performance, ruminal measurements, methane emission, digestibility, and nitrogen balance of dairy cows. J Dairy Sci 2019; 102:1281-1293. [PMID: 30591340 DOI: 10.3168/jds.2018-15041] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2018] [Accepted: 11/05/2018] [Indexed: 12/17/2023]
Abstract
Our objectives were to determine the effects of readily rumen-available carbohydrate source (refined starch vs. dextrose), the level of rumen-degradable protein (RDP), and their interaction on lactation performance, ruminal measurements, enteric methane (CH4) emission, nutrient digestibility, and nitrogen (N) balance in lactating dairy cows. Eighteen mid-lactation multiparous Holstein cows were used in this split-plot study. The main plots were created by randomly assigning 9 cows to diets of 11 or 9% RDP obtained by altering the percentage of soybean meal, expeller soybean meal, and blood meal in the diet. All diets included 16.4% crude protein. In the subplots, the effects of 0:10, 5:5, and 10:0 refined starch:dextrose ratio (% of dietary dry matter) were determined in three 3 × 3 Latin squares by randomly assigning the 9 cows in each RDP level into squares. Each period lasted 4 wk, with the last 2 wk allotted for sample collection. Carbohydrate source × RDP level interaction tended to influence dry matter intake (DMI), the concentration of urinary N, and urinary urea-N. Replacing refined starch with dextrose increased DMI, the molar percentage of ruminal butyrate and valerate, daily CH4 production (g/d), and fecal N and decreased the molar percentage of ruminal branched-chain volatile fatty acids, feed efficiency (fat- and protein-corrected milk/DMI), and N use efficiency (milk N/intake N) but did not influence nutrient digestibility. Enteric CH4 production was negatively related to the molar percentage of ruminal propionate but positively related to the molar percentage of ruminal butyrate. Treatments did not influence milk production responses, but cows fed 9% RDP diets had lower ruminal ammonia concentration (7.2 vs. 12.3 mg/dL) and tended to excrete less urinary purine derivatives (428 vs. 493 mmol/d) compared with cows fed 11% RDP diets, suggesting lower ruminal synthesis of microbial protein. Reducing the level of RDP in iso-nitrogenous diets had no effect on nutrient apparent total-tract digestibility, manure excretion and composition, N balance, and CH4 production. In this study, treatments did not affect yield (20.0 g of CH4/kg of DMI) or intensity (13.1 g of CH4/kg of fat- and protein-corrected milk), but methane production (g of CH4/d) was 7.0% lower and N use efficiency (conversion of intake N into milk protein) was 7.8% higher for cows fed a diet of 28.1% starch and 4.6% water-soluble carbohydrate compared with diets with lower starch and higher water-soluble carbohydrate contents.
Collapse
|
114
|
Yang JC, Yang ZR, Yu SQ, Zhan SY, Sun F. [Introduction on 'assessing the risk of bias of individual studies' in systematic review of health-care intervention programs revised by the Agency for Healthcare Research and Quality]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2019; 40:106-111. [PMID: 30669741 DOI: 10.3760/cma.j.issn.0254-6450.2019.01.021] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
This paper summarizes the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions revised by the Agency for Healthcare Research and Quality (AHRQ) and introduces how to use Revman software make risk of bias graph or risk of bias summary. AHRQ tool can be used to evaluate following study designs: RCTs, cohort study, case-control study (including nested case-control), case series study and cross-sectional study. The tool evaluates the risk of bias of individual studies from selection bias, performance bias, attrition bias, detection bias and reporting bias. Each of the bias domains contains different items, and each item is available for the assessment of one or more study designs. It is worth noting that the appropriate items should be selected for evaluation different study designs instead of using all items to directly assess the risk of bias. AHRQ tool can be used to evaluate risk of bias individual studies when systematic reviews of health care interventions is including different study designs. Moreover, the tool items are relatively easy to understand and the assessment process is not complicated. AHRQ recommends the use of high, medium and low risk classification methods to assess the overall risk of bias of individual studies. However, AHRQ gives no recommendations on how to determine the overall bias grade. It is expected that future research will give corresponding recommendations.
Collapse
|
115
|
Banfill K, Sun F, Mcwilliam A, Abravan A, Lilley J, Wheller R, Falk S, Schmitt M, Van Herk M, Franks K, Faivre-Finn C. Avoiding cardiac toxicity in patients undergoing curative intent radiotherapy for lung cancer. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30263-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
116
|
Sun F, Littlejohns A, Fakih O, Clarke K, Franks K, Snee M, Dickinson P, Jain P. An audit of sequential chemoradiotherapy for non-small cell lung cancer (NSCLC) at the Leeds Cancer Centre (LCC). Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30231-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
117
|
Zhang Y, Yang ZR, Sun F, Zhan SY. [Risk of bias assessment: (9) Application of the risk of bias assessment results]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2018; 39:1648-1654. [PMID: 30572394 DOI: 10.3760/cma.j.issn.0254-6450.2018.12.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
In this last paper of the series about risk of bias assessment, we introduce the application of risk of bias assessment results. Risk of bias assessment is one of the key steps in the assessment of quality of evidence. The risk of bias assessment results could be the "diagnosis" of individual studies, which helps decision making related to the inclusion and exclusion of individual studies, as well as the data analysis in the systematic review process. This paper focuses on how to incorporate risk of bias assessment results in the GRADE assessment for quality of evidence, including the principles and the tips for the application.
Collapse
|
118
|
Zha Y, Sun F. [Evaluation of protein-energy wasting in maintenance hemodialysis patients]. ZHONGHUA YI XUE ZA ZHI 2018; 98:3388-3391. [PMID: 30440132 DOI: 10.3760/cma.j.issn.0376-2491.2018.42.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
|
119
|
Hong L, Park N, Sun F. JOB SATISFACTION EVALUATION OF EMPLOYEES IN CHINA: AGE DIFFERENCES. Innov Aging 2018. [DOI: 10.1093/geroni/igy031.3429] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
120
|
Liu Y, Sun F, Marsiglia F, Roberto A. ADVANCE CARE PLANNING AMONG CHINESE AMERICAN OLDER ADULTS: AN EXPLORATORY STUDY. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.1708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
121
|
Jiang L, Sun F, Zhang W, Wu B, Dong X. SOMATIZATION AND HEALTH SERVICE USE AMONG CHINESE AMERICAN ELDERS: THE INFLUENCE OF ACCULTURATION. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.3158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
122
|
Sun F, Kennedy T. IMPROVEMENT OF PRACTICE OF ADULT PROTECTIVE SERVICES IN ARIZONA: IN-TAKE AND INVESTIGATION PROCESS REVIEW. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.2892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
123
|
Amano T, Shen H, Sun F. THE INFLUENCE OF GRANDPARENTING ON COGNITIVE FUNCTION AND THE MEDIATING ROLE OF HEALTH FACTORS. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.430] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
124
|
Burke R, Frank L, Sun F, Golden A, O’Hare A, Fabiny A. INSIGHTS FROM THE EXECUTIVE BRANCH: FELLOW EXPERIENCES IN FEDERAL AGENCIES AND ORGANIZATIONS. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.747] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
125
|
Lin Y, Gao LX, Li L, Wang JL, Shen JJ, Sun F, Qiu JH, Zha DJ. [Etiology analysis and vestibular assessment of bilateral vestibular vestibulopathy]. LIN CHUANG ER BI YAN HOU TOU JING WAI KE ZA ZHI = JOURNAL OF CLINICAL OTORHINOLARYNGOLOGY, HEAD, AND NECK SURGERY 2018; 32:379-382. [PMID: 29798299 DOI: 10.13201/j.issn.1001-1781.2018.05.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 11/06/2017] [Indexed: 11/12/2022]
Abstract
Objective:To define clinical and laboratory characteristics of bilateral vestibulopathy(BVP) and to propose diagnostic criteria of this disorder based on clinical and laboratory vestibular function test findings.Method:Forty-two case series with a clinical suspicion of BVP were retrospectively analyzed, in an attempt to determine etiology. Presenting auditory-vestibular symptoms, bedside dynamic visual acuity tests and laboratory test were reviewed, including bithermal caloric test, rotatory chair tests, video head impulse test (vHIT), vestibular-evoked myogenic potentials (VEMP).Result:Among these 42 patients, dizziness was seen in 42 cases(100%), oscillopsia was seen in 21 cases(50%), hearing loss was seen in 30(71.4%). Eight cases(19%) had tinnitus. Twenty-five cases showed vestibular loss in dynamic visual acuity test (69.4%). Definite diagnosis of complete BVP was made in 36 patients when the patients showed abnormal findings on caloric test, rotatory chair test and vHIT in addition to the symptoms. Whereas probable diagnosis of partial BVP was obtained in 6 patients with abnormal caloric test and rotatory chair test but no pathological vHIT. VEMP (ocular or cervical) could be recorded in 20 patients. Fourteen cases were caused by ototoxic drugs while no causes could be determined in 6 cases among these 42 cases.Conclusion:The diagnosis of BVP is a challenge. Vestibular laboratory test battery which reflect full frequency function of VOR has great value to confirming the diagnosis and differentiate complete BVP to partial BVP. Diagnosis standard shall be made combining clinical history, characteristic symptoms and the results of auditory-vestibular function testing. Ototoxic drugs contribute most considering etiology.
Collapse
|